We are live on ! Find out more
CC

Capital Counsel Portfolio holdings

AUM $2.35B
1-Year Est. Return 21.34%
This Fund
S&P 500
This Quarter Est. Return
+11.85%
1 Year Est. Return
+21.34%
3 Year Est. Return
+69.88%
5 Year Est. Return
+102.01%
10 Year Est. Return
+473.12%
AUM
$2.47B
AUM Growth
+$208M
Cap. Flow
-$24.6M
Cap. Flow %
-1%
Top 10 Hldgs %
89.22%
Holding
60
New
4
Increased
11
Reduced
25
Closed
3

Top Buys

Rank Stock Value
1
KGC icon
Kinross Gold
KGC
+$2.27M
2
INTC icon
Intel
INTC
+$925K
3
IONS icon
Ionis Pharmaceuticals
IONS
+$430K
4
EME icon
Emcor
EME
+$289K
5
RAL
Ralliant Corp
RAL
+$250K

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$4.11M
2
COST icon
Costco
COST
+$3.88M
3
MTD icon
Mettler-Toledo International
MTD
+$3.08M
4
IDXX icon
Idexx Laboratories
IDXX
+$2.98M
5
MSFT icon
Microsoft
MSFT
+$2.6M

Sector Composition

Rank Sector Weight
1 Technology 33.62%
2 Financials 20.31%
3 Healthcare 18.06%
4 Consumer Staples 10.3%
5 Communication Services 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTVA icon
51
Corteva
CTVA
$52.6B
$237K 0.01%
3,179
– –
QQQ icon
52
Invesco QQQ Trust
QQQ
$453B
$228K 0.01%
+414
New +$206K
VNT icon
53
Vontier
VNT
$4.52B
$225K 0.01%
6,090
– –
AVGO icon
54
Broadcom
AVGO
$1.85T
$221K 0.01%
+800
New +$174K
FLO icon
55
Flowers Foods
FLO
$1.49B
$186K 0.01%
11,610
– –
VUZI icon
56
Vuzix
VUZI
$194M
$58.4K ﹤0.01%
20,000
– –
NRGV icon
57
Energy Vault
NRGV
$517M
$47K ﹤0.01%
65,625
-6,100
-9% -$4.93K
AMGN icon
58
Amgen
AMGN
$208B
– –
-686
Closed -$214K
LLY icon
59
Eli Lilly
LLY
$1.02T
– –
-462
Closed -$382K
MRNA icon
60
Moderna
MRNA
$21.8B
– –
-8,727
Closed -$247K
1 2
3

Similar funds

HFM
Harvest Fund Management Beijing, China $2.35B AUM 49.85% 1-Year Est. Return
ROIC
Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.36B AUM 23.72% 1-Year Est. Return
G
GenTrust Miami, Florida $2.34B AUM 18.43% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
BAM
Berkshire Asset Management Wilkes Barre, Pennsylvania $2.33B AUM 19.33% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return

Capital Counsel's Q2 2025 Portfolio in Review

As of Q2 2025, Capital Counsel held 60 positions worth $2.47B, up 9.2% from $2.26B the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Capital Counsel's Q2 2025 filing shows 4 new, 11 increased, 25 reduced and 3 closed positions. Its largest new stake was Emcor: 654 shares worth $350K. The largest sale was Visa, an estimated $4.11M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 31% a quarter earlier, followed by Financials and Healthcare.

  • Capital Counsel's largest Q2 2025 buy was Emcor: 654 shares worth $350K.
  • Capital Counsel added most to Kinross Gold in Q2 2025, an estimated $2.27M increase.
  • Capital Counsel's biggest Q2 2025 reduction was Visa, cutting an estimated $4.11M.
  • Capital Counsel fully exited Eli Lilly in Q2 2025, selling an estimated $382K.
  • Capital Counsel's ten largest holdings make up 89% of its $2.47B portfolio in Q2 2025.
  • Capital Counsel opened 4 new positions and closed 3 in Q2 2025.
  • Capital Counsel's portfolio value rose 9.2% quarter-over-quarter to $2.47B.

Based on Capital Counsel's 13F filing for Q2 2025, filed 13 Aug 2025.